Your browser doesn't support javascript.
loading
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome.
Gerds, Aaron T; Scott, Bart L; Greenberg, Peter; Lin, Tara L; Pollyea, Daniel A; Verma, Amit; Dail, Monique; Feng, Yuning; Green, Cherie; Ma, Connie; Medeiros, Bruno C; Yan, Mark; Yousefi, Kasra; Donnellan, William.
Afiliação
  • Gerds AT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Scott BL; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Greenberg P; Stanford Cancer Institute, Stanford, CA.
  • Lin TL; University of Kansas Medical Center, University of Kansas, Kansas City, KS.
  • Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, CO.
  • Verma A; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
  • Dail M; Genentech, Inc., South San Francisco, CA.
  • Feng Y; Genentech, Inc., South San Francisco, CA.
  • Green C; Genentech, Inc., South San Francisco, CA.
  • Ma C; Genentech, Inc., South San Francisco, CA.
  • Medeiros BC; Genentech, Inc., South San Francisco, CA.
  • Yan M; Hoffmann-La Roche, Ltd, Mississauga, ON, Canada; and.
  • Yousefi K; Hoffmann-La Roche, Ltd, Mississauga, ON, Canada; and.
  • Donnellan W; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN.
Blood Adv ; 6(4): 1152-1161, 2022 02 22.
Article em En | MEDLINE | ID: mdl-34932793
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Anticorpos Monoclonais Humanizados Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Anticorpos Monoclonais Humanizados Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article